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1684-1182/Copyright ª 2015, TaiwanAbstract Background/objectives: Community-associated methicillin-resistant Staphylo-
coccus aureus (CA-MRSA) was recognized as a leading pathogen and has been shown to be
genetically different from the health care-associated MRSA (HA-MRSA). Photodynamic therapy
(PDT) is considered a potential alternative method for the treatment of resistant bacterial in-
fections, but the effect of PDT on CA-MRSA is unknown. The purpose of this study was to
compare the bactericidal effects of toluidine blue O (TBO) on CA-MRSA and HA-MRSA and inves-
tigate the photodynamic inactivation effects of TBO (TBO-PDI) against bacterial virulence fac-
tors.
Materials and methods: TBO-PDI effects were determined by measuring the survival fractions
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10.1016/j.jmii.2014.12.007influences of TBO-PDI on DNA fragmentation and the activities of protease, lipase, staphylo-
coccal a-hemolysin, and enterotoxin were studied.
Results: TBO-PDI has effective bactericidal activity against both CA- and HA-MRSA. However,
the bactericidal activity of TBO-PDI was significantly higher against HA-MRSA than CA-MRSA iso-
lates. In addition, TBO-PDI treatment using a sublethal TBO concentration led to reduced pro-
duction of several virulence factors, including protease, lipase, staphylococcal a-hemolysin,
and enterotoxin.
Conclusion: Although TBO-PDI is slightly less effective against CA-MRSA than HA-MRSA isolates,
TBO-PDI could reduce the production of virulence factors at a sublethal TBO concentration,
which would be beneficial for treating CA-MRSA infections.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) in-
fections are difficult to treat and are major clinical prob-
lems. During the past 10 years, the prevalence of hospital
associated MRSA (HA-MRSA) in Taiwan has increased.1 In
addition, community-associated (CA)-MRSA was recognized
and found to be genetically different from HA-MRSA.2,3 HA-
MRSA frequently infects elderly patients, commonly displays
multidrug resistance, and carries a type I, II, or III SCCmec
cassette. By contrast, CA-MRSA usually infects younger pa-
tients, and is more susceptible to non b-lactam antibiotics,
and usually carries a type IV or V SCCmec cassette.2,4,5
CA-MRSA frequently causes skin and soft tissue in-
fections (SSTIs)6,7 and sometimes results in severe in-
fections such as necrotizing pneumonia or sepsis.2,8 A
retrospective study showed that treatment failure for CA-
MRSA SSTIs was mainly due to inappropriate MRSA ther-
apy.9 The authors reported that treatment failure occurred
in 16 of 312 patients (5%) who received an active antibiotic
compared to 29 of 219 patients (13%) who received an
inactive antibiotic (p Z 0.001; Chi-square analysis). How-
ever, active antibiotic therapy can only be started after the
results of the antibiotic susceptibility test are available.
This process takes time and is performed by either bacteria
culture-based methods or through an automated system.
Photodynamic inactivation (PDI) may be an alternative
therapeutic option for the treatment of SSTIs because it has
several benefits. First, it is a local treatment and thus does
not provoke systemic effects in humans. Second, no PDI-
resistant bacteria have been reported, and third, low-cost
light sources are available.10,11
The mechanism of PDI was activation of nontoxic
photosensitizer (toluidine blue O), which was exposed to
appropriate wavelength, consequently providing reactive
oxygen species including free radicals and singlet oxygen.
These reactive oxygen species can damage DNA and bacte-
rial cell membrane, leading to bacterial death.10 PDI has
been shown to effectively inactivate or kill microbial path-
ogens.12e16 and has been used for chemical disinfection17,18
or plaque-disclosing agents.19 Various photosensitizers, such
as hematoporphyrin,20 phenothiazinium salts,21 chlorin,22,23
or 5-aminolevulinic acid,21,24 have been used in PDI and has
been shown to be bactericidal against S. aureus. Comparisonng S-P, et al., Effects of toluidine
aureus isolates, Journal of Micof the bactericidal effects of PDI against MRSA and
methicillin-susceptible Staphylococcus aureus (MSSA) has
been previously studied,25,26 but very few reports focused
on CA-MRSA. In this study, we compared the bactericidal
effects of TBO-PDI on CA-MRSA and HA-MRSA and investi-
gated the efficacy of TBO-PDI against bacterial virulence
factors such as protease, lipase, staphylococcal a-hemo-
lysin, and enterotoxin type B.
Materials and methods
Bacterial strains
CA-MRSA isolates (N Z 26) and HA-MRSA isolates (N Z 26)
were collected from the Bacteriology Laboratory in the
National Taiwan University Hospital (NTUH, Taipei), a uni-
versity hospital with 2,500 beds in northern Taiwan. CA-
MRSA isolates (N Z 26) were recovered from various spec-
imens as described in our previous study27 and HA-MRSA
isolates were recovered from blood cultures.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using disc
diffusion according to the guidelines from the Clinical and
Laboratory Standards Institute (CLSI).28 The following anti-
microbial agents were tested: oxacillin (by cefoxitin),
gentamicin, clindamycin, erythromycin, teicoplanin, mino-
cycline, trimethoprim-sulfamethoxazole, and vancomycin.
SCCmec typing
The SCCmec types of the 26 CA-MRSA and 26 HA-MRSA
clinical isolates were determined by types of the ccr
genes and class of mec complexes using polymerase chain
reaction and/or sequencing, which has been previously
described.29
Killing curve of TBO-PDI on MRSA isolates
The PDI assay was performed as described in our previous
study.14 Briefly, bacteria were grown in 20 mL of trypticase
soy broth (BD BBL, Franklin Lakes, NJ, USA) to an opticalblue O (TBO)-photodynamic inactivation on community-associated
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then harvested by centrifugation at 5,600 g for 15 minutes
and resuspended in phosphate buffered saline to a concen-
tration of 108 colony forming unit (CFU)/mL. The bacterial
suspensions were then incubated with a final concentration
of TBO (0mM, 0.25mM, 0.5mM, 0.75mM, 1mM, and 2mM) and
placed in 96-well microtiter plates. After incubation in the
dark at room temperature (RT) for 20 minutes, the bacterial
suspensions were exposed to 20 J of red light/cm2 (630 nm,
50mW/cm2 for 6minutes and 40 seconds) or kept in the dark.
The light source consisted of a high power light-emitting
diode (LED) array with the wavelength centered at
630  5 nm and a bandwidth of 20 nm. The LED light source
was fed by a small Direct Current (DC)-power supply. The
size of the LED array is able to cover a 96-well plate with a
power density of 50 mW/cm2. The amount of bacteria that
survived was assessed using the colony counting method.
The survival fraction was defined as the ratio of bacterial
CFU’s posttreatment to pretreatment.
DNA fragmentation analysis
Bacterial cells (109 CFU/mL) were incubated with various
TBO concentrations (0mM, 0.25mM, 0.5mM, 1mM, and 2mM)
and placed in 96-well microtiter plates. After incubation in
the dark at RT for 20 minutes, the bacterial suspensions
were either exposed to 20 J of red light/cm2 or kept in the
dark. After treatment, the bacterial DNA was prepared and
analyzed via pulsed-field gel electrophoresis (PFGE) as
described previously.14 The DNA was then separated on a
CHEF-DRIII unit (Bio-Rad Laboratories, Hercules, CA, USA).
Optimal separation was achieved using a pulse time of 5e30
seconds for 20 hours at 6 V/cm.
Protease and lipase activities assay
The protease and lipase activities were determined using
the plate method.15,30 Wells were dug into skim milk and
Salt-Tween agar plates using a 6-mm, 200 mL pipette tip. The
bacterial suspensions (108 CFU/mL) were incubated with
varying TBO concentrations (0mM, 0.25mM, 0.5mM, 1mM, and
2mM) and placed in 96-well microtiter plates. After incuba-
tion in the dark at RT for 20 minutes, the bacterial suspen-
sions were either exposed to 20 J of red light/cm2 or kept in
the dark. In order to make sure all tests containing same
bacteria concentration, 40 mL of the bacterial suspensions
(after incubation with various TBO concentrations) con-
taining 105 CFU/mL were placed into each well. The plates
were incubated at 37C for 48 h. Then, the diameters of the
hydrolyzed zone were measured. The experiments were
performed in triplicate. The skim milk agar contained 5.0 g/
L skim milk, 10.0 g/L yeast extract, and 12.5 g/L Bacto agar.
The Salt-Tween agar contained 10.0 g/L peptone, 10.0 g/L
yeast extract, 75.0 g/L NaCl, 0.1 g/L CaCl2H2O, 10.0 g/L
Tween 80, and 15.0 g/L Bacto agar, pH 7.2.
Western blot analysis of staphylococcal enterotoxin
type B and a-hemolysin
After treatment with PDI as previously described, the
bacteria were disrupted using sonication and centrifuged atPlease cite this article in press as: Tseng S-P, et al., Effects of toluidine
methicillin-resistant Staphylococcus aureus isolates, Journal of Mic
10.1016/j.jmii.2014.12.00715,000  g. The supernatant was collected as the protein
sample and stored at 20C until use. The protein con-
centrations were determined using the Bradford assay (Bio-
Rad Laboratories) with Bovine Serum Albumin (BSA) as the
standard. Samples containing equal amounts of cellular
proteins were separated on a 12% sodium dodecyl sulfate
polyacrylamide gel electrophoresis gel, and the gels were
then electroblotted into Immobilon-NC transfer membranes
(Millipore, Bedford, MA, USA). Enterotoxin type B and a-
hemolysin were detected by Western blot analysis using a
1:10000 dilution of rabbit anti-Staphylococcal enterotoxin B
(SEB) affinity purified immunoglobulin G (IgG) and sheep
anti-a-hemolysin affinity purified IgG, which were pur-
chased from Toxin Technology (Sarasota, FL, USA). The
blots were then washed and incubated with a 1:10000
dilution of goat anti-rabbit IgG-horseradish peroxidase
(HRP) conjugated secondary antibody or rabbit anti-sheep
IgG HRP conjugated secondary antibody (Sigma Aldrich,
St. Louis, MO, USA). The proteins were detected using the
enhanced chemiluminescence (ECL) detection system (ECL
Western Blotting Substrate, Pierce Biotechnology, Rock-
ford, IL, USA). Bands were scanned and quantified with the
gel analysis software Image (Quantity One; Bio-Rad
Laboratories).
Bactericidal activities on CA-MRSA and HA-MRSA
isolates
The bactericidal activity assay was slightly modified from
our previous study.14 Briefly, the overnight bacterial sus-
pensions were adjusted to 108 CFU/mL, added to 96-well
microtiter plates, and incubated with TBO at 1mM. After
incubation in the dark at RT for 20 minutes, the bacterial
suspensions were exposed to 20 J of red light/cm2 or kept in
the dark. Subsequently, 20 mL of the bacterial suspension
from each well was placed onto MuellereHinton agar (MHA;
Difco, Detroit, MI, USA) for 20 hours at 37C.
Statistical analysis
The GraphPad Prism software (GraphPad Prism Software
Inc., San Diego, CA, USA) was used for the statistical
analysis. One-way analysis of variance (ANOVA) with
correction for the multiple comparisons (Bonferroni post
hoc test) was used to test the difference between killing
curves of TBO-PDI on five MRSA strains. A nonparametric
test (ManneWhitney U test) was used to test the difference
between effect of TBO-PDI on plasmid degradation, pro-
tease activities, lipase activities, staphylococcal a-hemo-
lysin and enterotoxin type B. A p value< 0.05 was
considered significant.
Results
Characterization of the isolates
For 26 CA-MRSA isolates, 11 harbored type IV SCCmec ele-
ments and 11 harbored type V* SCCmec elements. Most of
the (21/26) HA-MRSA isolates harbored type II (nZ 10) or III
(n Z 11) SCCmec types. The gentamicin resistance ratesblue O (TBO)-photodynamic inactivation on community-associated
robiology, Immunology and Infection (2015), http://dx.doi.org/
Table 1 Characteristics of community-associated and hospital-associated methicillin-resistant Staphylococcus aureus clinical
isolates
MRSA Specimen SCCmec Antibiotic resistance (No. of isolates)
CC E GM SXT MI
Community-
associated
(n Z 26)
Abscess (1); bronchial washing (1);
blood (1); discharge (2); ear (1);
eye (2); pus (5); skin pus (3);
sputum (5); surgical wound (2);
throat swab (1); urine (2)
II (1); III (3);
IV (11); V*(11)
22 22 13 4 3
Hospital-
associated
(n Z 26)
Blood (26) II (10); III (11);
IV (2); V*(3)
24 24 22 11 7
All were resistant to oxacillin, but susceptible to teicoplanin and vancomycin.
CC Z clindamycin; E Z erythromycin; GM Z gentamicin; MI Z minocycline; MRSA Z methicillin-resistant Staphylococcus aureus;
SXT Z trimethoprim-sulfamethoxazole.
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(22/26) groups (Table 1).
Killing curves of TBO-PDI on five MRSA strains
The killing curves of TBO-PDI were determined on five
MRSA strains (ATCC 33592, 1 HA-MRSA, and 3 CA-MRSA
isolates). ATCC 33592 and HA-MRSA_MY8703 carry the
SCCmec III element, and CA-MRSA _194 carry SCCmec IV,
CA-MRSA_3, and CA-MRSA R32 contain SCCmec V* element,
respectively. TBO at a concentration of  2mM without
light did not have bactericidal activity (Fig. 1). TheFigure 1. Survival fractions of MRSA bacteria (108 cells/mL) inc
followed by dark or by light illumination: CA-MRSA _194, CA-MRS
incubated with various concentrations of TBO for 20 minutes at RT
cm2. Each data point represents the mean  standard error of thr
one-way analysis of variance (GraphPad Prism software) to correct
*, p＜0.05). Filled squareZ CA-MRSA_3 with varying concentration
with varying concentrations of TBO that was kept in the dark, fill
followed by illumination, empty circle Z CA-MRSA_R32 with var
cross Z CA-MRSA_194 with varying concentrations of TBO followe
concentrations of TBO that was kept in the dark, filled diamondZ H
illumination, empty diamondZ HA-MRSA_MY8703 with varying conc
ATCC33592 with varying concentrations of TBO followed by illum
centrations of TBO that was kept in the dark. CA-MRSA Z commun
MRSA Z healthcare-associated methicillin-resistant Staphylococcu
Please cite this article in press as: Tseng S-P, et al., Effects of toluidine
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bating the bacteria with different concentrations of TBO
(0mM, 0.25mM, 0.5mM, 0.75mM, 1mM, and 2mM) for 20 mi-
nutes at RT and then exposing them to 20 J of red light
illumination (Fig. 1). A strong bactericidal effect that
resulted in a 6e7-log reduction of bacterial cells was
found at a TBO concentration of 2mM for all five strains.
Slightly different bactericidal activities were found among
isolates (ATCC 33592jHA-MRSA_MY8703＞CA-MRSA_3j
CA-MRSA_R32＞CA-MRSA _194) when the TBO concentra-
tions were 0.5mM, 0.75mM, and 1mM (Fig. 1). At a TBO
concentration of 0.5mM, CA-MRSA_3, CA-MRSA_R32, andubated with various concentrations of toluidine blue O (TBO)
A_3, CA-MRSA_R32, HA-MRSA_MY8703, and ATCC 33592 were
and were then kept in the dark or exposed to 20 J of red light/
ee experiments. The statistical analysis was performed using a
for multiple comparisons (Bonferroni multiple comparison test;
s of TBO followed by illumination, empty squareZ CA-MRSA_3
ed circle Z CA-MRSA_R32 with varying concentrations of TBO
ying concentrations of TBO that was kept in the dark, filled
d by illumination, empty cross Z CA-MRSA_194 with varying
A-MRSA MY8703 with varying concentrations of TBO followed by
entrations of TBO that was kept in dark, filled triangleZ MRSA
ination, empty triangle Z MRSA ATCC33592 with varying con-
ity-associated methicillin-resistant Staphylococcus aureus; HA-
s aureus.
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reductions of viability, but ATCC33592 and HA-
MRSA_MY8703 showed 3.9-log and 3.3-log reductions in
viability, respectively. At a TBO concentration of 0.75mM,
CA-MRSA_3, CA-MRSA_R32, and CA-MRSA _194 showed 2.8-
log, 3.5-log reductions and 2.3-log of viability, but
ATCC33592 and HA-MRSA_MY8703 showed 6.8-log and 5.5-
log reductions in viability, respectively. At a TBO con-
centration of 1mM, CA-MRSA_3, CA-MRSA_R32, and CA-
MRSA _194 showed 5.8-log, 6.0-log, and 4.5-log re-
ductions and ATCC33592 and HA-MRSA_MY8703 showed
7.2-log and 7.8-log reductions in viability, respectively.
Thus, TBO-PDI had a greater bactericidal effect on HA-
MRSA_MY8703 and ATCC33592 than on CA-MRSA isolates.
These differences were statistically significant as deter-
mined by a one-way ANOVA (GraphPad Prism software)
with correction for the multiple comparisons (Bonferroni
post hoc test).
Effect of TBO-PDI on DNA fragmentation
TBO-PDI treatment resulted in chromosomal DNA frag-
mentation (50e100 kb) and plasmid degradation in MRSA. In
particular, plasmid degradation was dependent on the TBO
dose (Fig. 2). Plasmid degradation of MRSA were reduced
after PDI with TBO concentrations of 0.5mM, 1mM, and 2mM
(p < 0.05 using the ManneWhitney U test). The intensity of
the compression zone (arrow in Fig. 2) increased with
greater TBO concentrations. These results are consistent
with our previous finding in Pseudomonas aeruginosa, inFigure 2. Chromosomal DNA fragments were analyzed by pulse
were treated with toluidine blue O (TBO) for 20 minutes at room tem
cm2. Lane M, DNA size marker (lambda ladder PFG marker); Lane 1,
2, DC, dark control (2mM of TBO, no light); Lane 3, photodynamic in
with TBO (0.5mM) and light (20 J); Lane 5, PDI with TBO (1mM) and lig
represents the compression zone and the degraded plasmid. Each b
Data are expressed relative to the DC values, which are arbitrari
analysis using ManneWhitney U test). CA-MRSA Z community
MRSA Z healthcare-associated methicillin-resistant Staphylococcu
Please cite this article in press as: Tseng S-P, et al., Effects of toluidine
methicillin-resistant Staphylococcus aureus isolates, Journal of Mic
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photo-damaged by TBO-PDI.14
Effect of TBO-PDI on protease and lipase activities
CA-MRSA_3, isolated from skin pus, represents a major clone
of CA-MRSA isolates analyzed by PFGE.27 Thus we used this
strain for the testing. Production of virulence factors of CA-
MRSA_3 were tested by TBO-PDI treatment under the sub-
lethal TBO concentration. After TBO-PDI treatment, the
bacterial suspensions were adjusted from 108 CFU/mL to
105 CFU/mL and 40 mL of the bacterial suspensions were
placed into each well. The hydrolyzed zones were measured
to determine the protease and lipase activities. Negative
control, dark control, and light control conditions had
similarly sized hydrolyzed zones for the protease and lipase
activities (Fig. 3). The protease activity after TBO-PDI was
significantly decreased with a TBO concentration of 0.25 mM
(p < 0.05 by ManneWhitney U test), whereas the lipase
activity was slightly decreased at a TBO concentration of
0.25 mM. Both the protease and lipase activities of MRSA
were reduced after PDI with TBO concentrations of 0.5mM,
1mM, and 2mM (p < 0.05 using the ManneWhitney U test).
Effect of TBO-PDI on staphylococcal a-hemolysin
and enterotoxin type B
The effects of TBO-PDI on the staphylococcal a-hemolysin
and enterotoxin type B were determined by Western blot
analysis (Figs. 4 and 5). Similar levels of a-hemolysin andd-field gel electrophoresis: CA-MRSA 3 (109 CFU/mL) bacteria
perature (RT) with or without illumination of 20 J of red light/
LC, light control (630 nm, 20 J of red light/cm2, no TBO); Lane
activation (PDI) with TBO (0.25mM) and light (20 J); Lane 4, PDI
ht (20 J); Lane 6, PDI with TBO (2mM) and light (20 J). The arrow
ar represents the mean  standard error of three experiments.
ly set at 1.0. * p < 0.05 versus dark control group (statistical
-associated methicillin-resistant Staphylococcus aureus; HA-
s aureus.
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Figure 3. The protease and lipase activities were determined using the plating method: community-associated methicillin-
resistant Staphylococcus aureus (CA-MRSA) 3 (108 CFU/mL) bacteria were treated with various concentrations of toluidine blue O
(TBO) for 20 minutes at room temperature (RT) with or without illumination of 20 J of red light/cm2. Bacterial suspensions were
adjusted to 105 CFU/mL and 40 mL of the bacterial suspensions were placed into each well. Photodynamic inactivation (PDI) with
different concentrations of TBO and light (20 J) were shown in different bars. Each bar represents the mean  standard error of
three experiments. Asterisks indicate a statistically significant decrease (p < 0.05 using the ManneWhitney U test). DC Z dark
control (2mM of TBO, no light); LCZ light control (630 nm, 20 J of red light/cm2, no TBO); NC Z native control (without TBO and
illumination).
Figure 4. Photodynamic inactivation (PDI) effects on
staphylococcal a-hemolysin were measured by Western blot
analysis: community-associated methicillin-resistant Staphy-
lococcus aureus (CA-MRSA) 3 (108 CFU/mL) were treated with
0mM, 0.25mM, 0.5mM, 1mM, and 2mM of toluidine blue O (TBO)
for 20 minutes at room temperature (R) with or without illu-
mination of 20 J of red light/cm2. PDI with TBO (0.25mM,
0.5mM, 1mM, and 2mM of TBO) and light (20 J) were shown in
different bars. Each bar represents the mean  standard error
of three experiments. Data are expressed relative to the LC
values, which are arbitrarily set at 1.0. * p < 0.05 versus LC
group (statistical analysis using ManneWhitney U test).
DC Z dark control (4mM of TBO, no light); LC Z light control
(630 nm, 20 J of red light/cm2, no TBO).
Figure 5. Photodynamic inactivation (PDI) effects on
staphylococcal enterotoxin b were measured by Western blot
analysis: community-associated methicillin-resistant Staphy-
lococcus aureus (CA-MRSA) 3 (108 CFU/mL) were treated with
0mM, 0.25mM, 0.5mM, 1mM, and 2mM of toluidine blue O (TBO)
for 20 minutes at room temperature (RT) with or without illu-
mination of 20 J of red light/cm2. PDI with TBO (0.25mM,
0.5mM, 1mM, and 2mM of TBO) and light (20 J) were shown in
different bars. Each bar represents the mean  standard error
of three experiments. Data are expressed relative to the LC
values, which are arbitrarily set at 1.0. * p < 0.05 versus LC
group (statistical analysis using ManneWhitney U test).
DC Z dark control (4mM of TBO, no light); LC Z light control
(630 nm, 20 J of red light/cm2, no TBO).
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control or light control conditions (Figs. 4 and 5). After
TBO-PDI treatment, the tested CA-MRSA strain showed a
significant reduction in the expression of a-hemolysin and
enterotoxin type B (p < 0.05 using the MannWhitney U
test). It should be noted that only a 0.28-log reduction of
bacterial cells counts was observed with a TBO concentra-
tion of 0.25mM (Fig. 1). These data indicate that TBO-PDI
inhibited the expression of virulence factors at sublethal
TBO concentrations.
Comparison of bactericidal activity of TBO-PDI
against CA-MRSA and HA-MRSA isolates
Because of the genetic differences between the CA-MRSA
and HA-MRSA isolates, the efficacy of TBO-PDI against the
strains may not be the same. Thus, we tested bactericidal
activity on CA-MRSA and HA-MRSA isolates. Our results
indicate the majority of HA-MRSA responded better to TBO-
PDI than CA-MRSA (Table 2). Comparison of bactericidal
activity on different SCCmec types of isolates indicates that
SCCmec type IV and V* (22 CA-MRSA and 5 HA-MRSA) showed
less sensitive than SCCmec II and III (4 CA-MRSA and 21 HA-
MRSA) (Table 2).
Discussion
Increasing resistance to antibiotics in MRSA is a global
concern. For this reason, PDI, for which the bactericidal
effect works through a different mechanism, has been
considered an alternative and effective therapeutic op-
tion.17,18 Previous reports have shown bactericidal activity
of PDI with TBO or methylene blue (MB) against MRSA iso-
lates.12,26 However, most studies focused on comparing the
effects of PDI between MRSA and MSSA strains, whereas the
efficacy of PDI against CA-MRSA was largely unknown. Thus,
in the current study, we focused on comparing PDI against
CA-MRSA and HA-MRSA isolates. For more clinical applica-
tion, we used epidemiological criteria for defining the HA-
and CA-MRSA. The emergence of MRSA with CA genotypes
(i.e., SCCmec IV, V) strains as nosocomial isolates may
complicate the compositions of CA- and HA-MRSA strains.
Our results indicate that TBO-PDI significantly but differ-
entially inhibited the survival of both CA-MRSA and HA-
MRSA. By killing curve assay of two HA-MRSA and three
CA-MRSA, as well as bactericidal activities against more
isolates (a total of 26 CA-MRSA and 26 HA-MRSA) support
this finding. If compared by SCCmec types, isolates
harboring SCCmec II or III (HA-MRSA) were slightly moreTable 2 Comparison of bactericidal activities of toluidine blu
methicillin-resistant Staphylococcus aureus and 26 healthcare-as
isolates
log10- unit reduction Community-associated MRSA (n Z 2
SCCmec II SCCmec III SCCmec IV SC
< 3 0 2 11 11
 3 (3 to 8) 1 1 0 0
MRSA Z methicillin-resistant Staphylococcus aureus.
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MRSA). One study found that PDI activity against S. aureus
was correlated with the specific agr/SCCmec pattern.31 The
other study illustrated that clonal complex 1 accounted for
elevated resistance and CC30 (ST36) for susceptibility to
photoinactivation.32 The reason for different activity
against CA-MRSA and HA-MRSA is unknown, but may be due
to different genetic backgrounds including the sequencing
types and SCCmec types.2,3 Another possibility is the dif-
ference of specimen (HA-MRSA isolates were from blood
and CA-MRSA isolates were from various specimens), and
this difference could also be related to different genetic
background of isolates.
Photodamage to the DNA and the cytoplasmic membrane
have been proposed as possible mechanisms of PDI in bac-
teria.10 An in vitro study using hematoporphyrin-PDI against
S. aureus demonstrated that PDT resulted in photodamage
to cytoplasmic membrane proteins, chromosomal and
plasmid DNA.20 Furthermore, PDI may also induce oxidative
stress-derived DNA damage and lead to the production of
7,8-dihydro-8-oxo-20-deoxyguanosine (8-oxodG).33 This
modification of guanidine could cause DNA misreplication
and fragmentation.34 Our study showed that PDI treatment
caused chromosomal DNA fragmentation (50e100 kb) and
plasmid DNA degradation (Fig. 2).
To reduce the selective pressure for the development of
drug-resistant bacteria, antivirulence strategies and
several compounds have been developed.35 A similar
strategy can be achieved using TBO-PDI. It has been re-
ported that virulence factors are significantly reduced by
TBO-PDI treatment in Escherichia coli, P. aeruginosa,14,36
and Porphyromonas gingivalis13; however, the study of ef-
fect on staphylococcal virulence factors was limited in the
literature. One study showed that PDI with phenothiazinum
MB inhibited the purified protein activities of V8 protease,
a- hemolysin, and sphingomyelinase in S. aureus in a dose-
dependent manner.37 In the current study, we found that
TBO-PDI at a sub-lethal TBO concentration, as low as
0.25mM, inhibited the activities of the protease, lipase,
staphylococcal a-hemolysin, and enterotoxin type B pro-
duced by CA-MRSA stains. These results indicate that even
CA-MRSA_3 showed only a 1.7-log reduction of viability at a
TBO concentration of 0.5mM, TBO-PDI still effectively
reduced the production of virulence factors. A study by
Tubby et al37 also reported that extensive virulence factors
could be reduced by photodynamic therapy. These results
imply that it may be possible to treat CA-MRSA infections by
using low-dose photosensitizer through inhibition of the
production of virulence factors; even the bactericidal ef-
fect is only partial.38e O-photodynamic inactivation for 26 community-associated
sociated methicillin-resistant Staphylococcus aureus clinical
6) Hospital-associated MRSA (n Z 26)
Cmec V* SCCmec II SCCmec III SCCmec IV SCCmec V*
0 6 2 3
10 5 0 0
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+ MODELPDI has been previously shown to effectively reduce
bacteria in surgical and burn wound models that were
infected with an HA-MRSA strain.39,40 Similar animal models
may be used to test the effectiveness on CA-MRSA in-
fections. If we can successfully treat these infections, we
may decrease the incidence of serious CA-MRSA infections
and reduce health care costs. In addition, the strength of
reducing bacterial virulence factors under low dose of PDI
indicates the effective strategy for treating SSTIs caused by
CA-MRSA.
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